Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
Recruiting · NCT05598632 · Observational (researchers observe without assigning treatment) · Lead sponsor: China National Center for Cardiovascular Diseases
View the official record on ClinicalTrials.gov →What this trial is about
This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.
Who can take part
Age range
18 Years to 120 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- 18 years of age or older; male or female.
- History of documented atrial fibrillation.
- Able to provide written informed consent.
Exclusion criteria
- Subjects with moderate or severe mitral stenosis or a mechanical heart valve
- Subjects with previous or planned AF ablation.
- Subjects with previous or planned left atrial appendage closure.
- Subjects unable to cooperate with follow-up after assessment.
Where it is running
1 location listed.
- Fuwai Hospital, CAMS & PUMC - Beijing, Beijing Municipality, China